Preview
Unable to display preview. Download preview PDF.
Références
Winge K, Fowler CJ (2006) Bladder dysfunction in parkinsonism: mechanisms, prevalence, symptoms and management. Mov Disord 21(6): 737–745
Berger Y, Blaivas JG, De La Rocha ER, et al. (1987) Urodynamic findings in Parkinson’s disease. J Urol 138: 836–838
Andersen JT (1985) Disturbances of bladder and uretheral function in Parkinson’s disease. Int Urol Nephrol 17: 35–41
Araki I, Kuno S (2000) Assessment of voiding dysfunction in Parkinson’s disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 68: 429–433
Campos-Sousa RN, Quagliato E, da Silva BB, et al. (2003) Urinary symptoms in Parkinson’s disease: prevalence and associated factors. Arc Neuropsychiatr 61: 359–363
Winge K, Shau A-M, Stimpel H, et al. (2006) Prevalence of bladder dysfunction in Parkinson disease. Neurourol Urodyn 25: 116–122
Sakakibara R, Shinotoh H, Uchiyama T, et al.. (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92: 76–85
Martinez-Martin P, Schapira AHV, Stocchi F, et al. (2007) Prevalence of non motor symptoms in Parkinson’s disease in an international setting study using non motor symptoms questionnaire in 545 patients. Mov Disord 22: 1623–1629
Chandiramani VA, Palace J, Fowler CJ (1997) How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol 80: 100–104
Araki I, Kitahara M, Oida T, et al. (2000) Voiding dysfunction and Parkinson’s disease: urodynamic abnormalities and urinary symptoms. J Urol 164: 1640–1643
Sakakibara R, Hattori T, Uchiyama T, et al. (2001) Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 71: 600–606
Winge K, Werdelin LM, Nielsen KK, et al. (2004) Effects of dopaminergic treatment on bladder function in Parkinson’s disease. Neurourology and Urodynamics 23: 689–696
Sakakibara R, Shinotoh H, Uchiyama T, et al. (2001) SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson’s disease with urinary dysfunction. J Neurol Sci 187: 55–59
Hashimoto K, Oyama T, Sugiyama T, et al. (2003) Neuronal excitation in the ventral segmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats. J Pharmacol Sci 92: 143–148
Athwal BS, Berkley KJ, Hussain I, et al. (2001) Brain responses to changes in bladder volume and urge to void in healthy men. Brain 124: 369–377
Blok BF, Willemsen AT, Holstege G (1997) A PET study on brain control of micturition in humans. Brain 120: 111–121
Mattay VS, Tessitore A, Callicott JH, et al. (2002) Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Ann Neurol 51: 156–164
Kumar S, Bhatia M, Behari M (2002) Sleep disorders in Parkinson’s disease. Mov Disord 17: 775–781
Van Kerrebroeck P, Abrams P, Chaikin D, et al. (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee in the international continence society 21: 179–183
Zesiewicz TA, Baker MJ, Wahba M, et al. (2003) Autonomic nervous system dysfunction in Parkinson’s disease. Curr Treat Options Neurol 5: 149–160
Escaf S, Cavallotti C, Ricci A, et al. (1994) Dopamine D1 et D2 receptors in the human ureter and urinary bladder. A radioligand binding and autoradiographic study. Br J Urol 73: 473–479
Winge K, Rasmussen D, Werdelin LM (2003) Constipation in neurological diseases. J Neurol Neurosurg Psychiatry 74: 13–19
Brusa L, Petta F, Pisani A (2007) Acute vs chronic effects of L-dopa on bladder function in patients with mild Parkinson’s disease. Neurology 68: 1455–1459
Yamamoto M (1997) Pergolide improves neurogenic bladder in patients with Parkinson’s disease. Mov Disord 12: 328
Christmas TJ, Kempster PA, Chapple CR, et al. (1988) Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet 2: 1451–1453
Aranda B, Cramer P (1993) Effects of apomorphine and L-dopa on the parkinsonian bladder. Neurourol Urodyn 12: 203–209
Fitzmaurice H, Fowler CJ, Richards D, et al. (1985) Micturition disturbance in Parkinson’s disease. Br J Urol 57: 652–656
Uchiyama T, Sakakibara R, Hattori T, et al. (2003) Shortterm effect of a single levodopa dose on micturitian disturbance in Parkinson’s disease patients with the wearing-off phenomenon. Mov Disord 18: 573–578
Finazzi-Agro E, Peppe A, d’Amico A, et al. (2003) Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson’s disease. J Urol 169: 1388–1391
Seif C, Herzog J, Van der Horst C, et al. (2004) Effects of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 55: 118–120
Winge K, Nielsen KK, Stimpel H, et al. (2007) Lower urinary tract symptoms and bladder control in advanced Parkinson’s disease: effects of deep brain stimulation in the subthalamic nucleus. Mov Disord 22(2): 220–225
Palace J, Chandiavamani VA, Fowler CJ (1997) Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve 20: 1396–1403
Lang AE, Obeso JA (2004) Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3: 309–316
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag France
About this chapter
Cite this chapter
Herbaut, A.G. (2011). La maladie de Parkinson. In: Les incontinences urinaires de l’homme. Springer, Paris. https://doi.org/10.1007/978-2-287-99160-8_19
Download citation
DOI: https://doi.org/10.1007/978-2-287-99160-8_19
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-99159-2
Online ISBN: 978-2-287-99160-8
eBook Packages: MedicineMedicine (R0)